seen from China
seen from United Kingdom
seen from Italy
seen from United States
seen from United States
seen from Germany
seen from United States
seen from Sweden
seen from United Kingdom
seen from Brazil
seen from United States
seen from United States
seen from Germany
seen from Malaysia
seen from United States
seen from United States
seen from Kuwait
seen from United States
seen from United States
seen from France
Avicore plans cargo airline by mid-2008, to invest Rs400 crore
Logistics start-up Avicore Aviation Pvt. Ltd plans to invest $100 million, or about Rs400 crore, to launch a new cargo airline before mid-2008 from the country’s first dedicated cargo airport at Nagpur.
The main Indian promoter is Abhay Lodha, managing director of Mumbai-based Topworth Group, which has interests in steel and power plants.
Anya is live and ready to show you everything. Watch her strip, dance, and perform exclusive shows just for you. Interact in real-time and make your fantasies come true.
Free to watch • No registration required • HD streaming
Arch Pharma buys two drug cos for Rs70 cr
Ajit Kaamath Arch Pharma said it will spend Rs70 crore to expand the two acquired facilities, of which Rs40 crore would be spent on Sibra and Rs30 crore would be invested on Watsol.
Arch Pharma buys two drug cos for Rs70 cr
The acquisition of Watsol would strategically supplement and further augment our global leadership position in the isoxazole business, thus, meeting the growing demand in the industry. The Sibra facility would enhance our API (active pharmaceuticals ingredients) business and open new avenues for us," said Ajit A. Kamath, chairman and managing director of Arch Pharma. Isoxazole is a semi-synthetic form of penicillin.
Arch Pharma buys two drug cos for Rs70 cr
The acquisition of Watsol would strategically supplement and further augment our global leadership position in the isoxazole business, thus, meeting the growing demand in the industry. The Sibra facility would enhance our API (active pharmaceuticals ingredients) business and open new avenues for us," said Ajit A. Kamath, chairman and managing director of Arch Pharma. Isoxazole is a semi-synthetic form of penicillin.
Arch Pharma buys two drug cos for Rs70 cr
The acquisition of Watsol would strategically supplement and further augment our global leadership position in the isoxazole business, thus, meeting the growing demand in the industry. The Sibra facility would enhance our API (active pharmaceuticals ingredients) business and open new avenues for us," said Ajit A. Kamath, chairman and managing director of Arch Pharma. Isoxazole is a semi-synthetic form of penicillin.
Anya is live and ready to show you everything. Watch her strip, dance, and perform exclusive shows just for you. Interact in real-time and make your fantasies come true.
Free to watch • No registration required • HD streaming
Arch Pharma buys two drug cos for Rs70 cr
The acquisition of Watsol would strategically supplement and further augment our global leadership position in the isoxazole business, thus, meeting the growing demand in the industry. The Sibra facility would enhance our API (active pharmaceuticals ingredients) business and open new avenues for us," said Ajit A. Kamath, chairman and managing director of Arch Pharma. Isoxazole is a semi-synthetic form of penicillin.
Arch Pharma buys two drug cos for Rs70 cr
The funds will come from private equity, debt and internal sources even as Arch Pharma explores another round of capital infusion from private equity, said Ajit Kamath Arch Pharma
Arch Pharma buys two drug cos for Rs70 cr
Ajit Kamath Arch Pharma said it will spend Rs70 crore to expand the two acquired facilities, of which Rs40 crore would be spent on Sibra and Rs30 crore would be invested on Watsol. Arch also said it had finalized the expansion of its Gurgaon facility near New Delhi at an investment of Rs65 crore and will set up the second phase of a corporate research and development facility in Taloja, near Mumbai, for Rs10 crore.
